Stockreport

Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032 | MarketsandMarkets™ [Yahoo! Finance]

Bio-Techne Corp  (TECH) 
Last bio-techne corp earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.bio-techne.com
PDF million by 2032 at a CAGR of 108.9%. The market is being primarily driven by the emerging potential of exosome-based liquid biopsy, which offers non-invasive options for [Read more]